| [1] |
Eulalio A, Huntzinger E, Izaurralde E. Getting to the root of miRNA-mediated gene silencing [J]. Cell, 2008, 132(1): 9–14.
|
| [2] |
Amiel J, de Pontual L, Henrion-Caude A. miRNA, development and disease [J]. Adv Genet, 2012, 80: 1–36.
|
| [3] |
Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer [J]. Nat Rev Cancer, 2006, 6(4): 259–269.
|
| [4] |
Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection [J]. Proc Natl Acad Sci U S A, 2008, 105(30): 10513–10518.
|
| [5] |
Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases [J]. Cell Res, 2008, 18(10): 997–1006.
|
| [6] |
Zhang Y, Liu D, Chen X, et al. Secreted monocytic miR-150 enhances targeted endothelial cell migration [J]. Mol Cell, 2010, 39(1): 133–144.
|
| [7] |
Fang C, Zhu DX, Dong HJ, et al. Serum microRNAs are promising novel biomarkers for diffuse large B cell lymphoma [J]. Ann Hematol, 2012, 91(4): 553–559.
|
| [8] |
Resnick KE, Alder H, Hagan JP, et al. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform [J]. Gynecol Oncol, 2009，112(1): 55–59.
|
| [9] |
Gilad S, Meiri E, Yogev Y, et al. Serum microRNAs are promising novel biomarkers[J]. PLoS One，2008，3(9)：e3148.
|
| [10] |
Resnick KE, Alder H, Hagan JP, et al. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform[J]. Gynecol Oncol，2009，112(1)：55–59.
|
| [11] |
Rani S, Gately K, Crown J, et al. Global analysis of serum microRNAs as potential biomarkers for lung adenocarcinoma [J]. Cancer Biol Ther，2013，14(12): 1104–1112.
|
| [12] |
Shen J, Todd NW, Zhang H, et al. Plasma microRNAs as potential biomarkers for non-small-cell lung cancer [J]. Lab Invest, 2011, 91(4): 579–587.
|
| [13] |
Markou A, Sourvinou I, Vorkas PA, et al. Clinical evaluation of microRNA expression profiling in non small cell lung cancer [J]. Lung Cancer, 2013, 81(3): 388–396.
|
| [14] |
Ye SB, Li ZL, Luo DH, et al. Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma [J]. Oncotarget, 2014, 5(14): 5439–5452.
|
| [15] |
Gorur A, Balci FS, Dogruer UN, et al. Determination of plasma microRNA for early detection of gastric cancer [J]. Mol Biol Rep, 2013, 40(3): 2091–2096.
|
| [16] |
Wang Y, Li L, Qu Z, et al. The expression of miR-30a* and miR-30e* is associated with a dualistic model for grading ovarian papillary serious carcinoma [J]. Int J Oncol, 2014, 44(6): 1904–1914.
|
| [17] |
Jiang X, Du L, Wang L, et al. Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer [J]. Int J Cancer, 2015, 136(4): 854–862.
|
| [18] |
Le HB, Zhu WY, Chen DD, et al. Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients [J]. Med Oncol, 2012, 29(5): 3190–3197.
|
| [19] |
Zhou H, Guo JM, Lou YR, et al. Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker [J]. J Mol Med (Berl), 2010, 88(7): 709–717.
|
| [20] |
Kurashige J, Kamohara H, Watanabe M, et al. Serum microRNA-21 is a novel biomarker in patients with esophageal squamous cell carcinoma [J]. J Surg Oncol, 2012, 106(2): 188–192.
|
| [21] |
Heneghan HM, Miller N, Lowery AJ, et al. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer [J]. Ann Surg, 2010, 251(3): 499–505.
|
| [22] |
Wang WT, Zhao YN, Yan JX, et al. Differentially expressed microRNAs in the serum of cervical squamous cell carcinoma patients before and after surgery [J]. J Hematol Oncol, 2014, 7(1): 6.
|
| [23] |
Yuxia M, Zhennan T, Wei Z. Circulating miR-125b is a novel biomarker for screening non-small-cell lung cancer and predicts poor prognosis [J]. J Cancer Res Clin Oncol, 2012, 138(12): 2045–2050.
|
| [24] |
Toiyama Y, Hur K, Tanaka K, et al. Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer [J]. Ann Surg, 2014, 259(4): 735–743.
|
| [25] |
Köberle V, Kronenberger B, Pleli T, et al. Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma [J]. Eur J Cancer, 2013, 49(16): 3442–3449.
|